Literature DB >> 22159694

Prevalence and risk factors of HPV infection among women from various provinces of the world.

Krishnakumar Vinodhini1, Santhanam Shanmughapriya, Bhudev C Das, Kalimuthusamy Natarajaseenivasan.   

Abstract

OBJECTIVE: We set to estimate the genotype-specific prevalence of human papilloma virus (HPV) and its associated risk factors responsible among women with normal and abnormal cytology by systematic literature survey.
METHODS: Reports on HPV prevalence published between 2000 and 2011 were retrieved. To be included, studies required information on cervical cytology, plus detailed descriptions of study populations, methods used to collect cervical samples, and assays used for HPV DNA detection and typing. Final analyses included 280 studies of which 120 were included in the final analysis. The OR, 95% CI and P value were calculated using SPSS 16.0.
RESULTS: Overall HPV prevalence in 576,281 women was estimated to be 32.1% (95% CI 32.098, 32.102). Corresponding estimates by region showed Eastern Asia (China) with the highest prevalence of about 57.7% of the HPV infection followed by South Central Asia (Indian subcontinent). The HPV prevalence was higher in less developed countries (42.2%) than in more developed regions (22.6%). The type-specific HPV prevalence study showed HPV 16 (9.5%) and 18 (6.2%) to be the prevalent type irrespective of the region of study. First coitus at a younger (≤ 15) age, increased number of pregnancies, increased number of sexual partners, use of contraceptives, smoking and chewing habit and early age at marriage were recognized as the significant risk factors for HPV infection. The phylogenetic analysis of HPV-16 showed the clustering of Indian sequence with the European and American sequences suggesting a similarity between HPV types. Even though the oncogenic proteins of HPV-16 detected in more developed and less developed regions clustered, the prevalence and the severity of the diseases among the less developed regions could be well explained as the exposure of the population to the possible associated risk factors concerning to the living conditions and nature of the life style adopted by the population.

Entities:  

Mesh:

Year:  2011        PMID: 22159694     DOI: 10.1007/s00404-011-2155-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  34 in total

Review 1.  Second-generation prophylactic HPV vaccines: successes and challenges.

Authors:  Mitchell Tyler; Ebenezer Tumban; Bryce Chackerian
Journal:  Expert Rev Vaccines       Date:  2013-12-18       Impact factor: 5.217

2.  Prevalence and genotype distribution of human papillomavirus among Hakka women in China.

Authors:  Xiang-Xing Zeng; Li-Xiang Yan; Xiu-Xia Huang; Cai-Hua He; Wei-Guo Liu; Wen-Qing Yuan; Yan-Ping Qiu; Zhi-Xiang Liu
Journal:  Ann Transl Med       Date:  2016-08

3.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

4.  Anal human papillomavirus infection among HIV-infected and uninfected men who have sex with men in Beijing, China.

Authors:  Yifei Hu; Han-Zhu Qian; Jiangping Sun; Lei Gao; Lu Yin; Xiangwei Li; Dong Xiao; Dongliang Li; Xiaoyun Sun; Yuhua Ruan; Douglas F Milam; Stephen W Pan; Yiming Shao; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

5.  Genotype-specific prevalence of human papillomavirus infection in asymptomatic Peruvian women: a community-based study.

Authors:  Juana Del Valle-Mendoza; Lorena Becerra-Goicochea; Miguel Angel Aguilar-Luis; Luis Pinillos-Vilca; Hugo Carrillo-Ng; Wilmer Silva-Caso; Carlos Palomares-Reyes; Andre-Alonso Taco-Masias; Ronald Aquino-Ortega; Carmen Tinco-Valdez; Yordi Tarazona-Castro; Cynthia-Wendy Sarmiento-Ramirez; Luis J Del Valle
Journal:  BMC Res Notes       Date:  2021-05-07

6.  Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria.

Authors:  Mohammed Mohammed Manga; Adeola Fowotade; Yusuf Mohammed Abdullahi; Aliyu Usman El-Nafaty; Danladi Bojude Adamu; Hamidu Umar Pindiga; Rasheed Ajani Bakare; Abimbola Olu Osoba
Journal:  Infect Agent Cancer       Date:  2015-10-02       Impact factor: 2.965

7.  Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?

Authors:  Donatella Panatto; Daniela Amicizia; Elisabetta Tanzi; Silvia Bianchi; Elena Rosanna Frati; Carla Maria Zotti; Piero Luigi Lai; Angela Bechini; Stefania Rossi; Roberto Gasparini
Journal:  BMC Infect Dis       Date:  2013-12-06       Impact factor: 3.090

8.  Risk factors associated with human papillomavirus infection status in a Korean cohort.

Authors:  H Lee; D-H Lee; Y-M Song; K Lee; J Sung; G Ko
Journal:  Epidemiol Infect       Date:  2013-10-21       Impact factor: 4.434

Review 9.  Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV.

Authors:  Simona Di Mario; Vittorio Basevi; Pier Luigi Lopalco; Sara Balduzzi; Roberto D'Amico; Nicola Magrini
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

10.  Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.

Authors:  Zizipho Z A Mbulawa; David Coetzee; Anna-Lise Williamson
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.